Author:
Lebrun C.,Chichmanian R.M.,Peyrade F.,Chatel M.,Frenay M.
Reference5 articles.
1. The bradykinin B2 agonist, RMP-7: A novel means of increasing delivery of chemo-therapeutic agents to gliomas;Bartus;J Neuro Oncol,1996
2. Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: A study with ondansetron;Dubois;Eur J Cancer,1992
3. Toxicity and side effects of ondansetron;Finn;Semin Oncol,1992
4. Specific 5-HT3 receptor antagonist (GR38032) slows colonic transit and reduces neurotensin (NT) response in man;Talley;Gut,1988
5. Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist;Gore;Aliment Pharmacol Ther,1990
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献